Welcome to the first CYANS Lecture Series. The Network would like to thank participants who joined us for these four sessions, that are particularly targeted at healthcare staff who care for patients with allergies, but who may not have undertaken specialist training in the subject.
For those of you who were unable to attend on the day, please find recordings below of each session.
If you have any queries, please contact the team at nss.cyans@nhs.scot
Lecture 1 – Dr Paul Turner – 12th May 2021 – Oral Immunotherapy for food allergy: dawn of a new era?
Oral immunotherapy for food allergy was first described in the Lancet in 1908 yet is not currently recommended for clinical practice. Current management of allergen avoidance and provision of rescue medication is not a treatment. How close are we to establishing desensitisation as a routine intervention for food allergy?
Dr Paul Turner is a Clinician Scientist and Honorary Consultant in Paediatric Allergy & Immunology at Imperial College London, and Clinical Associate Professor at the University of Sydney, Australia. His research, funded by the Medical Research Council, European Commission, NIHR and UK Food Standards Agency among others, focusses on the pathophysiology of severe allergic reaction to food. He is a member of the UK Food Standard Agency’s Science Council, the FAO.WHO Codex Expert Consultation on Risk Assessment of Food Allergens and leads the EAACI Taskforce on Food Allergen Thresholds.
Paul leads the food allergy desensitisation programme at St Mary’s Hospital, London; the team was awarded the Best UK Clinical Team by Allergy UK in 2018. Paul was also the recipient of the 2020 PhARf Award, awarded by the European Academy of Allergy and Clinical Immunology (EAACI). He is a consultant to Public Health England, and current chairperson of the BSACI Paediatric Allergy Group and the WAO Anaphylaxis Committee.
Lecture 2 – Professor Graham Roberts – 26th May 2021 – Young People, allergies and asthma
Graham Roberts is a Professor and Consultant in paediatric allergy and respiratory medicine at University of Southampton and University Hospital Southampton NHS Foundation Trust. He is also Director of the David Hide Asthma and Allergy Research Centre on the Isle of Wight. He chaired the recent EAACI European adolescent guideline and has undertaken a number of projects focused on understanding and improving self-management in adolescent patients.
Lecture 3 – Lynne Regent – 16th June 2021 – Patient and Parent Experience
Lynne Regent, CEO joined the Anaphylaxis Campaign as Chief Executive (CEO) in October 2008. Prior to taking up this role she spent 30 years working in the NHS in the UK, ultimately as Chief Executive of Crawley Primary Care Trust in the South East. As CEO of the Anaphylaxis Campaign her role is to ensure that the charity achieves its objective of helping people at risk of severe allergies live their lives.
The Anaphylaxis Campaign is the only UK wide charity to exclusively meet the needs of the growing numbers of people at risk from severe allergic reactions (anaphylaxis) by providing information and support relating to foods and other triggers such as latex, drugs and insect stings.
Lecture 4 – Dr Paul Turner – ‘Improving anaphylaxis care in the UK ‘- the new Resuscitation Council (UK) Anaphylaxis Guideline
Dr Paul Turner is a Clinician Scientist and Honorary Consultant in Paediatric Allergy & Immunology at Imperial College London, and Clinical Associate Professor at the University of Sydney, Australia. His research, funded by the Medical Research Council, European Commission, NIHR and UK Food Standards Agency among others, focusses on the pathophysiology of severe allergic reaction to food.
In this session, Dr Turner talks delegates through the new RCUK Anaphylaxis Guideline.
Lecture 5 – Dr Mariette Nortier, Dr Adrian Sie and Professor Colin Lumsden “How well are anaphylaxis patients in Scotland managed? – a data perspective”
This lecture discusses the importance of data capturing for anaphylaxis patients in Scotland. Each presenter shares experiences from a data perspective from NHS Boards across Scotland.